If you made any changes in Pure these will be visible here soon.

Research Output 1991 2019

  • 1879 Citations
  • 18 h-Index
  • 63 Article
  • 3 Review article
  • 1 Chapter
2019

Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the “Rete Ematologica Pugliese”

Di Renzo, N., Melillo, L., Porretto, F., Dargenio, M., Pavone, V., Pastore, D., Mazza, P., Mannina, D., Merenda, A., Cascavilla, N., Greco, G., Matera, R., Bonizzoni, E., Celio, L. & Musso, M., Jan 1 2019, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Open Access
aprepitant
Induction Chemotherapy
Acute Myeloid Leukemia
Vomiting
Drug Therapy

Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults

Karthaus, M., Schiel, X., Ruhlmann, C. H. & Celio, L., Jul 3 2019, In : Expert Review of Clinical Pharmacology. 12, 7, p. 661-680 20 p.

Research output: Contribution to journalReview article

Open Access
Neurokinin-1 Receptor Antagonists
Nausea
Vomiting
Drug Therapy
Antiemetics

One-Day Versus Three-Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data-Based Meta-Analysis

Okada, Y., Oba, K., Furukawa, N., Kosaka, Y., Okita, K., Yuki, S., Komatsu, Y., Celio, L. & Aapro, M., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalReview article

Open Access
Nausea
Dexamethasone
Vomiting
Meta-Analysis
Drug Therapy
5 Citations (Scopus)

Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives

Vernieri, C., Milano, M., Brambilla, M., Mennitto, A., Maggi, C., Cona, M. S., Prisciandaro, M., Fabbroni, C., Celio, L., Mariani, G., Bianchi, G. V., Capri, G. & de Braud, F., Jul 2019, In : Critical Reviews in Oncology/Hematology. 139, p. 53-66 14 p.

Research output: Contribution to journalReview article

Therapeutic Human Experimentation
Breast Neoplasms
Standard of Care
Treatment Failure
Pharmaceutical Preparations

Short-course olanzapine to prevent delayed emesis following carboplatin/paclitaxel for gynecologic cancer: a randomised study

Celio, L., Saibene, G., Lepori, S., Festinese, F., Niger, M., Raspagliesi, F. & Lorusso, D., Jun 1 2019, In : Tumori. 105, 3, p. 253-258 6 p.

Research output: Contribution to journalArticle

olanzapine
Carboplatin
Paclitaxel
Vomiting
Dexamethasone
1 Citation (Scopus)

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Vernieri, C., Prisciandaro, M., Milano, M., Cona, M. S., Maggi, C., Brambilla, M., Mennitto, A., Fabbroni, C., Farè, E., Cresta, S., Celio, L., Mariani, G., Bianchi, G., Capri, G. & de Braud, F., Apr 2019, In : Clinical Breast Cancer. 19, 2, p. e306-e318

Research output: Contribution to journalArticle

gemcitabine
Carboplatin
Breast Neoplasms
Safety
Disease-Free Survival
2018

Pro-netupitant/palonosetron (IV) for the treatment of radio-and-chemotherapy-induced nausea and vomiting

Celio, L. & Fabbroni, C., Aug 2018, In : Expert Opinion on Pharmacotherapy. 19, 11, p. 1267-1277 11 p.

Research output: Contribution to journalArticle

Radio
Nausea
Vomiting
Antiemetics
Drug Therapy
2017
46 Citations (Scopus)

2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy

Herrstedt, J., Roila, F., Warr, D., Celio, L., Navari, R. M., Hesketh, P. J., Chan, A. & Aapro, M. S., Jan 1 2017, In : Supportive Care in Cancer. 25, 1, p. 277-288 12 p.

Research output: Contribution to journalArticle

Emetics
aprepitant
Nausea
Vomiting
Cyclophosphamide
4 Citations (Scopus)

Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy

Restelli, U., Saibene, G., Nardulli, P., DI Turi, R., Bonizzoni, E., Scolari, F., Perrone, T., Croce, D. & Celio, L., Jul 1 2017, In : BMJ Open. 7, 7, e015645.

Research output: Contribution to journalArticle

Budgets
Nausea
Italy
Vomiting
fosaprepitant
2016

Prevention of cinv in patients receiving high-dose multiple-day chemotherapy

Celio, L., Jan 1 2016, Management of Chemotherapy-Induced Nausea and Vomiting: New Agents and New Uses of Current Agents. Springer International Publishing, p. 135-156 22 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Drug Therapy
Nausea
Vomiting
Antiemetics
Hematopoietic Stem Cell Transplantation
4 Citations (Scopus)
Nausea
Dexamethasone
Vomiting
Drug Therapy
Anthracyclines
2015
11 Citations (Scopus)

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: An evidence-based review of safety, efficacy, and place in therapy

Celio, L., Niger, M., Ricchini, F. & Agustoni, F., Aug 21 2015, In : Core Evidence. 10, p. 75-87 13 p.

Research output: Contribution to journalArticle

Nausea
Vomiting
Safety
Drug Therapy
Receptors, Serotonin, 5-HT3
2014
2 Citations (Scopus)
3 Citations (Scopus)

Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy

Mirabile, A., Celio, L., Magni, M., Bonizzoni, E., Gianni, A. M. & Di Nicola, M., Dec 1 2014, In : Future Oncology. 10, 16, p. 2569-2578 10 p.

Research output: Contribution to journalArticle

Vomiting
Appointments and Schedules
Antiemetics
Drug Therapy
Dexamethasone
2013
2 Citations (Scopus)

Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? Analysis of a phase II trial

Damian, S., Celio, L., De Benedictis, E., Mariani, P., Agustoni, F., Ricchini, F. & De Braud, F., Jun 2013, In : Oncology. 84, 6, p. 371-377 7 p.

Research output: Contribution to journalArticle

Paclitaxel
Doxorubicin
Dexamethasone
Vomiting
Breast Neoplasms
4 Citations (Scopus)

Palonosetron plus dexamethasone in highly emetogenic chemotherapy: Pooled data from two Phase III trials

Celio, L., Agustoni, F., Ricchini, F., Dotti, K., Niger, M. & Braud, F. D., Oct 2013, In : Future Oncology. 9, 10, p. 1451-1458 8 p.

Research output: Contribution to journalArticle

Dexamethasone
Drug Therapy
Nausea
Vomiting
Granisetron
18 Citations (Scopus)
Anthracyclines
Cyclophosphamide
Nausea
Dexamethasone
Vomiting
7 Citations (Scopus)

Research on chemotherapy-induced nausea: Back to the past for an unmet need?

Celio, L. & Aapro, M., Apr 1 2013, In : Journal of Clinical Oncology. 31, 10, p. 1376-1377 2 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)
fosaprepitant
Patient Safety
Nausea
Vomiting
aprepitant
2012
5 Citations (Scopus)

Palonosetron: An evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy

Celio, L., Agustoni, F., Testa, I., Dotti, K. & De Braud, F., May 2012, In : Tumori. 98, 3, p. 279-286 8 p.

Research output: Contribution to journalArticle

Nausea
Vomiting
Drug Therapy
Dexamethasone
Serotonin Receptors
12 Citations (Scopus)
Nausea
Dexamethasone
Vomiting
Drug Therapy
Antiemetics
2011
69 Citations (Scopus)

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: A randomized, multicenter, phase III trial

Celio, L., Frustaci, S., Denaro, A., Buonadonna, A., Ardizzoia, A., Piazza, E., Fabi, A., Capobianco, A. M., Isa, L., Cavanna, L., Bertolini, A., Bichisao, E. & Bajetta, E., Aug 2011, In : Supportive Care in Cancer. 19, 8, p. 1217-1225 9 p.

Research output: Contribution to journalArticle

Nausea
Dexamethasone
Vomiting
Drug Therapy
Cyclophosphamide
2009
7 Citations (Scopus)

Feasibility study of biweekly capecitabine, oxaliplatin, and irinotecan in patients with untreated advanced gastric cancer

Bajetta, E., Verzoni, E., Ferrario, E., Dotti, K., Gevorgyan, A. & Celio, L., Jan 2009, In : Tumori. 95, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Feasibility Studies
Stomach Neoplasms
Capecitabine
17 Citations (Scopus)

Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: A multi-institutional phase II study

Celio, L., Sternberg, C. N., Labianca, R., La Torre, I., Amoroso, V., Barone, C., Pinotti, G., Cascinu, S., Di Costanzo, F., Cetto, G. L. & Bajetta, E., 2009, In : Annals of Oncology. 20, 6, p. 1062-1067 6 p.

Research output: Contribution to journalArticle

oxaliplatin
Pemetrexed
Stomach Neoplasms
Confidence Intervals
Therapeutics
46 Citations (Scopus)
Merkel Cell Carcinoma
Recurrence
Incidence
Neck
Extremities
2008
10 Citations (Scopus)

Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting

Celio, L., Denaro, A., Canova, S., Gevorgyan, A. & Bajetta, E., Jul 2008, In : Tumori. 94, 4, p. 447-452 6 p.

Research output: Contribution to journalArticle

Nausea
Vomiting
Drug Therapy
Dexamethasone
Serotonin Antagonists
15 Citations (Scopus)

Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer

Cappelletti, V., Gariboldi, M., De Cecco, L., Toffanin, S., Reid, J. F., Lusa, L., Bajetta, E., Celio, L., Greco, M., Fabbri, A., Pierotti, M. A. & Daidone, M. G., Jun 2008, In : Endocrine-Related Cancer. 15, 2, p. 439-449 11 p.

Research output: Contribution to journalArticle

Estrogen Receptors
Estrogens
Breast Neoplasms
Gene Expression
Therapeutics
2007
31 Citations (Scopus)

Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer.

Bajetta, E., Celio, L., Ferrario, E., Di Bartolomeo, M., Denaro, A., Dotti, K., Mancin, M., Bajetta, R., Colombo, A. & Pusceddu, S., Nov 2007, In : Annals of Oncology. 18, 11, p. 1810-1816 7 p.

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Colorectal Neoplasms
Therapeutics
Metastasectomy
2006
10 Citations (Scopus)

Neuroendocrine tumors of the larynx: A clinical report and literature review

Procopio, G., Ricotta, R., Fusi, A., Celio, L., De Dosso, S., Catena, L., Ferrari, L., Quattrone, P., Verzoni, E. & Bajetta, E., Jan 2006, In : Tumori. 92, 1, p. 72-75 4 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Larynx
Neoplasms
Incidence
Therapeutics
2005
160 Citations (Scopus)

Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women

Bajetta, E., Procopio, G., Celio, L., Gattinoni, L., Della Torre, S., Mariani, L., Catena, L., Ricotta, R., Longarini, R., Zilembo, N. & Buzzoni, R., 2005, In : Journal of Clinical Oncology. 23, 10, p. 2155-2161 7 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Safety
Therapeutics
Capecitabine
Poisons
2004

Acute confusional state with fatal outcome in a cancer patient

Caraceni, A., Andreola, S., Simonetti, F. & Celio, L., Feb 2004, In : Neurological Sciences. 24, 6, p. 424-425 2 p.

Research output: Contribution to journalArticle

26 Citations (Scopus)

Prospective evaluation of estrogen receptor-β in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients

Cappelletti, V., Celio, L., Bajetta, E., Allevi, A., Longarini, R., Miodini, P., Villa, R., Fabbri, A., Mariani, L., Giovanazzi, R., Galante, E., Greco, M. & Daidone, M. G., Dec 2004, In : Endocrine-Related Cancer. 11, 4, p. 761-770 10 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Estrogen Receptor Modulators
Estrogen Receptors
Breast Neoplasms
Messenger RNA
2003
11 Citations (Scopus)

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

Ferrari, L., Bajetta, E., Martinetti, A., Celio, L., Longarini, R., La Torre, I., Buzzoni, R., Gattinoni, L., Seregni, E. & Bombardieri, E., May 2003, In : International Journal of Oncology. 22, 5, p. 1081-1089 9 p.

Research output: Contribution to journalArticle

exemestane
letrozole
Aminoglutethimide
Aromatase Inhibitors
Somatomedins
50 Citations (Scopus)

Phase II study of pemetrexed disodium (Alimta®) administered with oral folic acid in patients with advanced gastric cancer

Bajetta, E., Celio, L., Buzzoni, R., Ferrari, L., Marchianò, A., Martinetti, A., Longarini, R., Becerra, C., Ilardi, C. & John, W., Oct 2003, In : Annals of Oncology. 14, 10, p. 1543-1548 6 p.

Research output: Contribution to journalArticle

Pemetrexed
Folic Acid
Stomach Neoplasms
Neutropenia
2002
94 Citations (Scopus)

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

Bajetta, E., Ferrari, L., Procopio, G., Catena, L., Ferrario, E., Martinetti, A., Di Bartolomeo, M., Buzzoni, R., Celio, L., Vitali, M., Beretta, E., Seregni, E. & Bombardieri, E., 2002, In : Annals of Oncology. 13, 4, p. 614-621 8 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Combination Drug Therapy
Neoplasms
Therapeutics
Epirubicin
8 Citations (Scopus)

Pemetrexed in gastric cancer: Clinical experience and future perspectives

Celio, L., Buzzoni, R., Longarini, R., Marchianò, A. & Bajetta, E., Dec 2002, In : Seminars in Oncology. 29, 6 SUPPL. 18, p. 63-68 6 p.

Research output: Contribution to journalArticle

Pemetrexed
Stomach Neoplasms
Folic Acid
Folic Acid Antagonists
Esophagogastric Junction
14 Citations (Scopus)

Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

Ferrari, L., Martinetti, A., Zilembo, N., Pozzi, P., Buzzoni, R., La Torre, I., Gattinoni, L., Catena, L., Vitali, M., Celio, L., Seregni, E., Bombardieri, E. & Bajetta, E., 2002, In : Journal of Steroid Biochemistry and Molecular Biology. 80, 4-5, p. 411-418 8 p.

Research output: Contribution to journalArticle

Somatomedins
Breast Neoplasms
Insulin-Like Growth Factor Binding Protein 1
Aromatase Inhibitors
Insulin-Like Growth Factor Binding Protein 3
2000
309 Citations (Scopus)

Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: A phase II trial

Lønning, P. E., Bajetta, E., Murray, R., Tubiana-Hulin, M., Eisenberg, P. D., Mickiewicz, E., Celio, L., Pitt, P., Mita, M., Aaronson, N. K., Fowst, C., Arkhipov, A., Salle, E. D., Polli, A. & Massimini, G., Jun 2000, In : Journal of Clinical Oncology. 18, 11, p. 2234-2244 11 p.

Research output: Contribution to journalArticle

exemestane
Aromatase Inhibitors
Breast Neoplasms
Confidence Intervals
Aromatase
2 Citations (Scopus)

Adjuvant oophorectomy versus CMF in premenopausal node-positive breast cancer: Long-term results of an experience at the Milan Cancer Institute

Salvadori, B., Celio, L., Oriana, R. & Bajetta, E., May 2000, In : Tumori. 86, 3, p. 258-259 2 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)

New clinical trials for the treatment of neuroendocrine tumors

Bajetta, E., Bichisao, E., Artale, S., Celio, L., Ferrari, L., Di Bartolomeo, M., Zilembo, N., Stani, S. C. & Buzzoni, R., 2000, In : Quarterly Journal of Nuclear Medicine. 44, 1, p. 96-101 6 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Clinical Trials
Octreotide
Carcinoid Tumor
Therapeutics
4 Citations (Scopus)

Ovarian ablation for premenopausal early-stage breast cancer: An update

Celio, L., Bajetta, E., Toffolatti, L., Catena, L., Beretta, E. & Buzzoni, R., May 2000, In : Tumori. 86, 3, p. 191-194 4 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Castration
Ovariectomy
Gonadotropin-Releasing Hormone
Estrogens
7 Citations (Scopus)
Triptorelin Pamoate
Aromatase Inhibitors
Metabolism
Gonadotropin-Releasing Hormone
Bone
34 Citations (Scopus)

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

Bajetta, E., Zilembo, N., Bichisao, E., Martinetti, A., Buzzoni, R., Pozzi, P., Bidoli, P., Ferrari, L. & Celio, L., 2000, In : Annals of Oncology. 11, 8, p. 1017-1022 6 p.

Research output: Contribution to journalArticle

Aromatase Inhibitors
Estrogens
Breast Neoplasms
Neoplasms
Aromatase
1999
214 Citations (Scopus)

Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

Bajetta, E., Ferrari, L., Martinetti, A., Celio, L., Procopio, G., Artale, S., Zilembo, N., Di Bartolomeo, M., Seregni, E. & Bombardieri, E., Sep 1 1999, In : Cancer. 86, 5, p. 858-865 8 p.

Research output: Contribution to journalArticle

Chromogranin A
Neuroendocrine Tumors
Phosphopyruvate Hydratase
Carcinoembryonic Antigen
Acetic Acid
69 Citations (Scopus)

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients

Bajetta, E., Zilembo, N., Dowsett, M., Guillevin, L., Di Leo, A., Celio, L., Martinetti, A., Marchianò, A., Pozzi, P., Stani, S. & Bichisao, E., Feb 1999, In : European Journal of Cancer. 35, 2, p. 208-213 6 p.

Research output: Contribution to journalArticle

letrozole
Multicenter Studies
Breast Neoplasms
Thyroxine
Sex Hormone-Binding Globulin
7 Citations (Scopus)

Fluoropyrimidines in the treatment of advanced neoplastic diseases: Role and advantages of UFT

Del Vecchio, M., Procopio, G., Cassata, A., Pozzi, P., Busto, G., Celio, L. & Bajetta, E., Jan 1999, In : Tumori. 85, 1, p. 6-11 6 p.

Research output: Contribution to journalArticle

Fluorouracil
Uracil
Colorectal Neoplasms
Tegafur
Antimetabolites
48 Citations (Scopus)
Aromatase Inhibitors
Gonadotropin-Releasing Hormone
Breast Neoplasms
Triptorelin Pamoate
Estrogens
1998
18 Citations (Scopus)

Effects of short-term pre-operative tamoxifen on steroid receptor and Ki-67 expression in primary breast cancer: An immunocytochemical study

Bajetta, E., Celio, L., Di Leo, A., Bartoli, C., Pilotti, S., Leutner, M., Bono, A., Ferrari, L., Buzzoni, R., Zilembo, N., De Candis, D. & Moglia, D., Apr 1998, In : International Journal of Oncology. 12, 4, p. 853-858 6 p.

Research output: Contribution to journalArticle

Steroid Receptors
Tamoxifen
Fine Needle Biopsy
Breast Neoplasms
Ki-67 Antigen
7 Citations (Scopus)
Dacarbazine
Interferons
Cisplatin
Glutathione
Melanoma
1997
1 Citation (Scopus)

Effects of aromatase complex selective inhibition on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 circulating levels in breast cancer

Ferrari, L., Bajetta, E., Seregni, E., Martinetti, A., Zilembo, N., Noberasco, C., Buzzoni, R., Botti, C., Massaron, S., Bichisao, E., Celio, L. & Bombardieri, E., 1997, In : International Journal of Oncology. 11, 1, p. 163-167 5 p.

Research output: Contribution to journalArticle

Insulin-Like Growth Factor Binding Protein 3
Aromatase
Somatomedins
Breast Neoplasms
Aromatase Inhibitors